Tirzepatide
Weight management, Diabetes control, Cardiovascular health, Improves insulin sensitivity, Supports metabolic health.
Research Benefits
Available at
Pantheon Peptides
Affiliate disclosure: PeptidesMaxxing earns a commission at no cost to you.
What is Tirzepatide?
Tirzepatide is a dual GLP-1/GIP receptor agonist — a synthetic peptide that simultaneously activates two incretin hormone receptors to produce additive effects on blood glucose control, appetite suppression, and body weight reduction. It is FDA-approved as Mounjaro for type 2 diabetes and as Zepbound for chronic weight management.
The dual mechanism distinguishes Tirzepatide from earlier single-agonist GLP-1 agents, producing superior weight loss and glycemic control compared to any single-agonist compound in head-to-head clinical trials.
Mechanism of Action
GLP-1 Receptor Agonism
GLP-1 receptor activation in the brain reduces appetite and food intake. In the pancreas, it enhances glucose-dependent insulin secretion and reduces glucagon — improving blood sugar control. Gastric emptying slows, contributing to satiety.
GIP Receptor Agonism
The GIP component provides additive insulin sensitization, independent adipose tissue metabolic effects, and may contribute to Tirzepatide's superior muscle-preservation profile compared to GLP-1 monotherapy.
Key Research Findings
SURMOUNT Clinical Trials
The SURMOUNT-1 trial demonstrated average weight loss of 20.9% at 72 weeks with the highest Tirzepatide dose — a landmark result that established the new benchmark for pharmacological weight loss. Approximately 37% of participants achieved ≥25% weight loss.
Glycemic Control
In SURPASS clinical trials in type 2 diabetes, Tirzepatide produced superior HbA1c reductions compared to semaglutide — with a higher proportion of patients achieving normoglycemia (HbA1c <5.7%).
Cardiovascular Benefits
SURMOUNT-MMO trial data demonstrated significant reduction in major adverse cardiovascular events in overweight individuals — extending Tirzepatide's clinical profile beyond metabolic to cardiovascular protection.
Body Composition
Unlike older weight loss interventions, Tirzepatide produces primarily fat mass reduction with substantial lean mass preservation — a favorable body composition profile in clinical measurements.
*For research use only. Not for human consumption.*
Research Use Only: This product is for laboratory research purposes only. Not intended for human consumption. Not approved by the FDA for any therapeutic use. Consult a qualified physician before any use.
Ready to order Tirzepatide?
Research-grade purity from Pantheon Peptides.
Related Research
You Might Also Need
Reduces abdominal fat, enhances metabolic function, supports muscle maintenance, improves skin elasticity, enhance mental clarity.
Supports weight loss, helps preserve lean muscle, reduces food cravings, aids metabolic health, lowers blood pressure, improves blood sugar control.
Supports sustainable weight loss, reduces appetite and food cravings, enhances metabolic efficiency, preserves muscle mass during fat loss.